Update on diffuse alveolar hemorrhage and pulmonary vasculitis
- PMID: 23102067
- PMCID: PMC3483562
- DOI: 10.1016/j.iac.2012.08.001
Update on diffuse alveolar hemorrhage and pulmonary vasculitis
Abstract
Diffuse alveolar hemorrhage is a clinical syndrome that can be a manifestation of multiple different causes. Identification of the underlying etiology is of utmost importance and dictates treatment. Pulmonary vasculitis including antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a common cause of diffuse alveolar hemorrhage. For AAV, treatment includes induction followed by maintenance therapy. Rituximab has an increasing role in the treatment of AAV.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures
References
-
- Travis WD, Colby TV, Lombard C, et al. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol. 1990;14(12):1112–25. - PubMed
-
- Falk RJ, Gross WL, Guillevin L, et al. Granulomatosis with polyangiitis (wegener’s): An alternative name for wegener’s granulomatosis. Arthritis Rheum. 2011;63(4):863–4. - PubMed
-
- de Prost N, Parrot A, Picard C, et al. Diffuse alveolar haemorrhage: Factors associated with in-hospital and long-term mortality. Eur Respir J. 2010;35(6):1303–11. - PubMed
-
- Cordier JF, Cottin V. Alveolar hemorrhage in vasculitis: Primary and secondary. Semin Respir Crit Care Med. 2011;32(3):310–21. - PubMed
-
- Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest. 2010;137(5):1164–71. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
